Details for New Drug Application (NDA): 076698

NDA 076698 describes METOLAZONE, which is a drug marketed by Alembic, Ani Pharms, Bayshore Pharms Llc, Chemistry Hlth, Innogenix, Mylan, Ne Rx Pharma, Renata, Roxane, Rubicon, Sandoz, and Watson Labs, and is included in thirteen NDAs. It is available from eighteen suppliers. Additional details are available on the METOLAZONE profile page.

The generic ingredient in METOLAZONE is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.

Summary for 076698

Tradename:	METOLAZONE
Applicant:	Mylan
Ingredient:	metolazone
Patents:	0

Pharmacology for NDA: 076698

Physiological Effect

Increased Diuresis

Medical Subject Heading (MeSH) Categories for 076698

Antihypertensive Agents

Diuretics

Sodium Chloride Symporter Inhibitors

Suppliers and Packaging for NDA: 076698

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
METOLAZONE	metolazone	TABLET;ORAL	076698	ANDA	Mylan Pharmaceuticals Inc.	0378-6172	0378-6172-01	100 TABLET in 1 BOTTLE, PLASTIC (0378-6172-01)
METOLAZONE	metolazone	TABLET;ORAL	076698	ANDA	Mylan Pharmaceuticals Inc.	0378-6173	0378-6173-01	100 TABLET in 1 BOTTLE, PLASTIC (0378-6173-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	2.5MG
Approval Date:	Dec 23, 2003	TE:	AB	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Oct 19, 2004	TE:	AB	RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	10MG
Approval Date:	Oct 19, 2004	TE:	AB	RLD:	No

Complete Access Available with Subscription